| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Travere Therapeutics, Inc. (TVTX) have been net sellers, shedding 1,304,671 shares worth roughly $80.1M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. TVTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $11.64M | -243,735 | |
| VP | 117.1K | $2.62M | - | |
| Other | 105.4K | $6.88M | - | |
| VP | 100.5K | $6.56M | - | |
| Other | 98.2K | $1.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Lyons Gary A54 | Director | Sale+OE10b5-1 | 10,000 | $63.28 | $632,845.97 | -14.0% | - | - | |
| Jun 12, 2026 | Baynes Roy D. | Director | Sale+OE10b5-1 | 4,500 | $50.00 | $225,000.00 | -9.8% | +29.7% | - | |
| Jun 12, 2026 | Coughlin Timothy75 | Director | Sale+OE10b5-1 | 10,000 | $50.07 | $500,747.00 | -15.1% | +29.7% | - | |
| May 15, 2026 | Coughlin Timothy75 | Director | Sell10b5-1 | 3,250 | $43.49 | $141,342.50 | -5.9% | +44.2% | - | |
| May 6, 2026 | Cline Christopher R.48 | Chief Financial Officer | Sale+OE10b5-1 | 2,491 | $46.31 | $115,368.15 | -2.1% | +25.2% | - | |
| May 6, 2026 | Rote William E.58 | Chief Research Officer | Sale+OE10b5-1 | 2,763 | $43.95 | $121,433.85 | -2.3% | +25.2% | - | |
| May 6, 2026 | Reed Elizabeth E57 | Chief Legal Officer and GC | Sale+OE10b5-1 | 4,250 | $45.33 | $192,657.30 | -3.9% | +25.2% | - | |
| May 6, 2026 | Dube Eric M56 | Chief Executive Officer | Sale+OE10b5-1 | 22,500 | $43.95 | $988,875.00 | -4.9% | +25.2% | - | |
| May 6, 2026 | Inrig Jula | Chief Medical Officer | Sale+OE10b5-1 | 22,485 | $45.15 | $1,015,085.55 | -16.6% | +25.2% | - | |
| May 5, 2026 | Baynes Roy D. | Director | Sale+OE10b5-1 | 4,500 | $46.65 | $209,925.00 | -10.7% | +22.7% | - |